EIF2A and lung carcinoma: Furthermore, the activation of the UPR program via eIF2α phosphorylation indicates a previously unknown pathogenic effect of CS and suggests that chronic induction of one or more protein effectors of the UPR pathway may play an etiological role in lung cancer.